Neurotrophins and lung disease

Cytokine and Growth Factor Reviews

Volumn 14, Issue 6, 2003, Pages 551-558

  Hoyle, Gary W ^a  

^a TULANE UNIVERSITY HEALTH SCIENCES CENTER   (United States)

Author keywords

Asthma; Nerve growth factor; Neuroimmunology; Neurotrophins

Indexed keywords

GROWTH FACTOR; NERVE GROWTH FACTOR; NEUROTROPHIN; NEUROTROPHIN RECEPTOR;

ASTHMA; BRONCHOSPASM; BRONCHUS HYPERREACTIVITY; CYTOKINE PRODUCTION; FIBROBLAST; GENE EXPRESSION; HUMAN; INFLAMMATION; LUNG CANCER; LUNG DISEASE; LUNG FIBROBLAST; LUNG FIBROSIS; MAST CELL; MONOCYTE; NONHUMAN; PERIPHERAL NERVE; PRIORITY JOURNAL; REVIEW; TUMOR GROWTH;

ANIMALIA;

EID: 0142022104     PISSN: 13596101     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1359-6101(03)00061-3     Document Type: Review

References (77)

1. Levi-Montalcini R, Hamburger V. Selective growth stimulating effects of mouse sarcoma on the sensory and sympathetic nervous system of the chick embryo. J Exp Zool 1951;116:321-51.
2. Cohen S. Purification of a nerve-growth promoting protein from the mouse salivary gland and its neuro-cytotoxic antiserum. Proc Natl Acad Sci USA 1960;46:302-11.
3. Bocchini V, Angeletti PU. The nerve growth factor: purification as a 30,000-molecular-weight protein. Proc Natl Acad Sci USA 1969;64:787-94.
4. Angeletti RH, Bradshaw RA. Nerve growth factor from mouse submaxillary gland: amino acid sequence. Proc Natl Acad Sci USA 1971;68:2417-20.
5. Ullrich A, Gray A, Berman C, Dull TJ. Human β-nerve growth factor gene sequence highly homologous to that of mouse. Nature 1983;303:821-5.
6. Barde YA, Edgar D, Thoenen H. Purification of a new neurotrophic factor from mammalian brain. EMBO J 1982;1:549-53.
7. Leibrock J, Lottspeich F, Hohn A, et al. Molecular cloning and expression of brain-derived neurotrophic factor. Nature 1989;341:149-52.
8. Maisonpierre PC, Belluscio L, Squinto S, et al. Neurotrophin-3: a neurotrophic factor related to NGF and BDNF. Science 1990;247:1446-51.
9. Ernfors P, Ibanez CF, Ebendal T, Olson L, Persson H. Molecular cloning and neurotrophic activities of a protein with structural similarities to nerve growth factor: developmental and topographical expression in the brain. Proc Natl Acad Sci USA 1990;87:5454-8.
10. Ip NY, Ibanez CF, Nye SH, et al. Mammalian neurotrophin-4: structure, chromosomal localization, tissue distribution, and receptor specificity. Proc Natl Acad Sci USA 1992;89:3060-4.
11. Berkemeier LR, Winslow JW, Kaplan DR, Nikolics K, Goeddel DV, Rosenthal A. Neurotrophin-5: a novel neurotrophic factor that activates trk and trkB. Neuron 1991;7:857-66.
12. Sutter A, Riopelle RJ, Harris-Warrick RM, Shooter EM. Nerve growth factor receptors. Characterization of two distinct classes of binding sites on chick embryo sensory ganglia cells. J Biol Chem 1979;254:5972-82.
13. Rodriguez-Tebar A, Barde YA. Binding characteristics of brain-derived neurotrophic factor to its receptors on neurons from the chick embryo. J Neurosci 1988;8:3337-42.
14. Rodriguez-Tebar A, Dechant G, Gotz R, Barde YA. Binding of neurotrophin-3 to its neuronal receptors and interactions with nerve growth factor and brain-derived neurotrophic factor. EMBO J 1992;11:917-22.
15. Johnson D, Lanahan A, Buck CR, et al. Expression and structure of the human NGF receptor. Cell 1986;47:545-54.
16. Radeke MJ, Misko TP, Hsu C, Herzenberg LA, Shooter EM. Gene transfer and molecular cloning of the rat nerve growth factor receptor. Nature 1987;325:593-7.
17. Kaplan DR, Martin-Zanca D, Parada LF. Tyrosine phosphorylation and tyrosine kinase activity of the trk proto-oncogene product induced by NGF. Nature 1991;350:158-60.
18. Klein R, Jing SQ, Nanduri V, O'Rourke E, Barbacid M. The trk proto-oncogene encodes a receptor for nerve growth factor. Cell 1991;65:189-97.
19. Meakin SO, Suter U, Drinkwater CC, Welcher AA, Shooter EM. The rat trk protooncogene product exhibits properties characteristic of the slow nerve growth factor receptor. Proc Natl Acad Sci USA 1992;89:2374-8.
20. Bothwell M. Functional interactions of neurotrophins and neurotrophin receptors. Annu Rev Neurosci 1995;18:223-53.
21. Smeyne M, Klein R, Schnapp A, et al. Severe sensory and sympathetic neuropathies in mice carrying a disrupted trk/NGF receptor gene. Nature 1994;368:246-9.
22. Jones KR, Farinas I, Backus C, Reichardt LF. Targeted disruption of the brain-derived neurotrophic factor gene perturbs brain and sensory neuron but not motor neuron development. Cell 1994;76:989-1000.
23. Ernfors P, Lee KF, Kucera J, Jaenisch R. Lack of neurotrophin-3 leads to deficiencies in the peripheral nervous system and loss of limb proprioceptive afferents. Cell 1994;77:503-12.
24. Lee K-F, Li E, Huber LJ, et al. Targeted mutation of the gene encoding the low affinity NGF receptor p75 leads to deficits in the peripheral sensory nervous system. Cell 1992;69:737-49.
25. Thomas SM, DeMarco M, D'Arcangelo G, Halegoua S, Brugge JS. Ras is essential for nerve growth factor- and phorbol ester-induced tyrosine phosphorylation of MAP kinases. Cell 1992;68:1031-40.
26. Ohmichi M, Decker SJ, Saltiel AR. Activation of phosphatidylinositol-3 kinase by nerve growth factor involves indirect coupling of the trk proto-oncogene with src homology 2 domains. Neuron 1992;9:769-77.
27. Widmer HR, Kaplan DR, Rabin SJ, Beck KD, Hefti F, Knusel B. Rapid phosphorylation of phospholipase C gamma 1 by brain-derived neurotrophic factor and neurotrophin-3 in cultures of embryonic rat cortical neurons. J Neurochem 1993;60:2111-23.
28. Qui MS, Green SH. PC12 cell neuronal differentiation is associated with prolonged p21ras activity and consequent prolonged ERK activity. Neuron 1992;9:705-17.
29. Hagag N, Halegoua S, Viola M. Inhibition of growth factor-induced differentiation of PC12 cells by microinjection of antibody to ras p21. Nature 1986;319:680-2.
30. Yao R, Cooper GM. Requirement for phosphatidylinositol-3 kinase in the prevention of apoptosis by nerve growth factor. Science 1995;267:2003-6.
31. Crowder RJ, Freeman RS. Phosphatidylinositol 3-kinase and Akt protein kinase are necessary and sufficient for the survival of nerve growth factor-dependent sympathetic neurons. J Neurosci 1998;18:2933-43.
32. Obermeier A, Bradshaw RA, Seedorf K, Choidas A, Schlessinger J, Ullrich A. Neuronal differentiation signals are controlled by nerve growth factor receptor/Trk binding sites for SHC and PLC gamma. EMBO J 1994;13:1585-90.
33. Roux PP, Barker PA. Neurotrophin signaling through the p75 neurotrophin receptor. Prog Neurobiol 2002;67:203-33.
34. Maggirwar SB, Sarmiere PD, Dewhurst S, Freeman RS. Nerve growth factor-dependent activation of NF-κB contributes to survival of sympathetic neurons. J Neurosci 1998;18:10356-65.
35. Hamanoue M, Middleton G, Wyatt S, Jaffray E, Hay RT, Davies AM. p75-mediated NF-κB activation enhances the survival response of developing sensory neurons to nerve growth factor. Mol Cell Neurosci 1999;14:28-40.
36. Crowley C, Spencer SD, Nishimura MC, et al. Mice lacking nerve growth factor display perinatal loss of sensory and sympathetic neurons yet develop basal forebrain cholinergic neurons. Cell 1994;76:1001-12.
37. Klein R, Smeyne RJ, Wurst W, et al. Targeted disruption of the trkB neurotrophin receptor gene results in nervous system lesions and neonatal death. Cell 1993;75:113-22.
38. Klein R, Silos-Santiago I, Smeyne RJ, et al. Disruption of the neurotrophin-3 receptor gene trkC eliminates la muscle afferents and results in abnormal movements. Nature 1994;368:249-51.
39. Stucky CL, Koltzenburg M. The low-affinity neurotrophin receptor p75 regulates the function but not the selective survival of specific subpopulations of sensory neurons. J Neurosci 1997;17:4398-405.
40. Lindsay RM, Lockett C, Sternberg J, Winter J. Neuropeptide expression in cultures of adult sensory neurons: modulation of substance P and calcitonin gene-related peptide levels by nerve growth factor. Neuroscience 1989;33:53-65.
41. Donnerer J, Schuligoi R, Stein C. Increased content and transport of substance P and calcitonin gene-related peptide in sensory nerves innervating inflamed tissue: evidence for a regulatory function of nerve growth factor in vivo. Neuroscience 1992;49:693-8.
42. Shu X, Mendell LM. Acute sensitization by NGF of the response of small-diameter sensory neurons to capsaicin. J Neurophysiol 2001;86:2931-8.
43. Ehrhard PB, Erb P, Grauman U, Otten U. Expression of nerve growth factor and nerve growth factor receptor tyrosine kinase Trk in activated CD4-positive T-cell clones. Proc Natl Acad Sci USA 1993;90:10984-8.
44. Ehrhard PB, Erb P, Graumann U, Schmutz B, Otten U. Expression of functional trk tyrosine kinase receptors after T cell activation. J Immunol 1994;152:2705-9.
45. Lambiase A, Bracci-Laudiero L, Bonini S, et al. Human CD4+ T cell clones produce and release nerve growth factor and express high-affinity nerve growth factor receptors. J Allergy Clin Immunol 1997;100:408-14.
46. Maroder M, Bellavia D, Meco D, et al. Expression of trKB neurotrophin receptor during T cell development. Role of brain derived neurotrophic factor in immature thymocyte survival. J Immunol 1996;157:2864-72.
47. Garcia-Suarez O, Blanco-Gelaz MA, Lopez ML, et al. Massive lymphocyte apoptosis in the thymus of functionally deficient TrkB mice. J Neuroimmunol 2002;129:25-34.
48. Brodie C, Gelfand EW. Functional nerve growth factor receptors on human B lymphocytes. Interaction with IL-2. J Immunol 1992;148:3492-7.
49. trk. Eur J Immunol 1996;26:1985-92.
50. Torcia M, Bracci-Laudiero L, Lucibello M, et al. Nerve growth factor is an autocrine survival factor for memory B lymphocytes. Cell 1996;85:345-56.
51. Ehrhard PB, Ganter U, Bauer J, Otten U. Expression of functional trk protooncogene in human monocytes. Proc Natl Acad Sci USA 1993;90:5423-7.
52. la Sala A, Corinti S, Federici M, Saragovi HU, Girolomoni G. Ligand activation of nerve growth factor receptor TrkA protects monocytes from apoptosis. J Leuk Biol 2000;68:104-10.
53. Aloe L, Levi-Montalcini R. Mast cells increase in tissue of neonatal rats injected with the nerve growth factor. Brain Res 1977;133:358-66.
54. Getchell ML, Kulkarni-Narla A, Takami S, Albers KM, Getchell TV. Age-dependent phenotypic switching of mast cells in NGF-transgenic mice. Neuroreport 1995;6:1261-6.
55. Horigome K, Pryor JC, Bullock ED, Johnson Jr EM. Mediator release from mast cells by nerve growth factor. Neurotrophin specificity and receptor mediation. J Biol Chem 1993;268:14881-7.
56. Horigome K, Bullock ED, Johnson Jr EM. Effects of nerve growth factor on rat peritoneal mast cells. Survival promotion and immediate-early gene induction. J Biol Chem 1994;269:2695-702.
57. Sawada J, Itakura A, Tanaka A, Furusaka T, Matsuda H. Nerve growth factor functions as a chemoattractant for mast cells through both mitogen-activated protein kinase and phosphatidylinositol 3-kinase signaling pathways. Blood 2000;95:2052-8.
58. Bonini S, Lambiase A, Bonini S, et al. Circulating nerve growth factor levels are increased in humans with allergic diseases and asthma. Proc Natl Acad Sci USA 1996;93:10955-60.
59. Virchow JC, Julius P, Lommatzsch M, Luttmann W, Renz H, Braun A. Neurotrophins are increased in bronchoalveolar lavage fluid after segmental allergen provocation. Am J Respir Crit Care Med 1998;158:2002-5.
60. Kassel O, de Blay F, Duvernelle C, et al. Local increase in the number of mast cells and expression of nerve growth factor in the bronchus of asthmatic patients after repeated inhalation of allergen at low-dose. Clin Exp Allergy 2001;31:1432-40.
61. Olgart Hoglund C, de Blay F, Oster JP, et al. Nerve growth factor levels and localisation in human asthmatic bronchi. Eur Resp J 2002;20:1110-6.
62. Braun A, Appel E, Baruch R, et al. Role of nerve growth factor in a mouse model of allergic airway inflammation and asthma. Eur J Immunol 1998;28:3240-51.
63. Path G, Braun A, Meents N, et al. Augmentation of allergic early-phase reaction by nerve growth factor. Am J Respir Crit Care Med 2002;166:818-26.
64. Sigurs N, Bjarnason R, Sigurbergsson F, Kjellman B. Respiratory syncytial virus bronchiolitis in infancy is an important risk factor for asthma and allergy at age 7. Am J Respir Crit Care Med 2000;161:1501-7.
65. Hu C, Wedde-Beer K, Auais A, Rodriguez MM, Piedimonte G. Nerve growth factor and nerve growth factor receptors in respiratory syncytial virus-infected lungs. Am J Physiol Lung Cell Mol Physiol 2002;283:L494-502.
66. de Vries A, Engels F, Henricks PA, Leusink-Muis T, Fischer A, Nijkamp FP. Antibodies directed against nerve growth factor inhibit the acute bronchoconstriction due to allergen challenge in guinea-pigs. Clin Exp Allergy 2002;32:325-8.
67. de Vries A, Dessing MC, Engels F, Henricks PA, Nijkamp FP. Nerve growth factor induces a neurokinin-1 receptor-mediated airway hyperresponsiveness in guinea pigs. Am J Respir Crit Care Med 1999;159:1541-4.
68. de Vries A, van Rijnsoever C, Engels F, Henricks PA, Nijkamp FP. The role of sensory nerve endings in nerve growth factor-induced airway hyperresponsiveness to histamine in guinea-pigs. Br J Pharmacol 2001;134:771-6.
69. Hoyle GW, Graham RM, Finkelstein JB, Nguyen KT, Gozal D, Friedman M. Hyperinnervation of the airways in transgenic mice overexpressing nerve growth factor. Am J Respir Cell Mol Biol 1998;18:149-57.
70. Braun A, Quarcoo D, Schulte-Herbruggen O, Lommatzsch M, Hoyle G, Renz H. Nerve growth factor induces airway hyperresponsiveness in mice. Int Arch Allergy Immunol 2001;124:205-7.
71. Koizumi H, Morita M, Mikami S, Shibayama E, Uchikoshi T. Immunohistochemical analysis of TrkA neurotrophin receptor expression in human non-neuronal carcinomas. Pathol Int 1998;48:93-101.
72. Ricci A, Greco S, Mariotta S, et al. Neurotrophins and neurotrophin receptors in human lung cancer. Am J Respir Cell Mol Biol 2001;25:439-46.
73. Missale C, Codignola A, Sigala S, et al. Nerve growth factor abrogates the tumorigenicity of human small cell lung cancer cell lines. Proc Natl Acad Sci USA 1998;95:5366-71.
74. Fiorentini C, Facchetti M, Finardi A, et al. Nerve growth factor and retinoic acid interactions in the control of small cell lung cancer proliferation. Eur J Endocrinol 2002;147:371-9.
75. Micera A, Vigneti E, Pickholtz D, et al. Nerve growth factor displays stimulatory effects on human skin and lung fibroblasts, demonstrating a direct role for this factor in tissue repair. Proc Natl Acad Sci USA 2001;98:6162-7.
76. Kohyama T, Liu X, Wen FQ, et al. Nerve growth factor stimulates fibronectin-induced fibroblast migration. J Lab Clin Med 2002;140:329-35.
77. Besser M, Wank R. Cutting edge: clonally restricted production of the neurotrophins brain- derived neurotrophic factor and neurotrophin-3 mRNA by human immune cells and Th1/Th2-polarized expression of their receptors. J Immunol 1999;162:6303-6.